Mitochondrial Hearing Loss: Genetic Variants and Clinical Progression

Area of Science:

• Genetics
• Otolaryngology
• Neurology

Background:

• Mitochondrial diseases impact multiple organs, including the auditory system, causing sensorineural hearing loss (SNHL).
• Mechanisms and progression of mitochondrial hearing loss are not fully understood.
• Several mitochondrial DNA (mtDNA) mutations are associated with progressive hearing impairment.

Purpose of the Study:

• To analyze the frequency and progression of mitochondrial mutations in patients with unexplained SNHL.
• To investigate the clinical course and phenotypic variability of mitochondrial hearing loss.
• To identify common mtDNA mutations linked to SNHL and their associated clinical implications.

Main Methods:

• Genetic testing of 15 patients diagnosed with unexplained SNHL.
• Analysis of mutation frequency and progression over time.
• Correlation analysis between heteroplasmy levels and hearing deterioration.

Main Results:

• The most frequent mutations identified were m.3243A>G and m.1555A>G.
• Hearing loss associated with m.3243A>G was generally progressive, with variable rates of deterioration.
• Hearing loss in m.1555A>G cases remained stable during the follow-up period.
• No significant correlation was found between heteroplasmy levels and hearing deterioration, though a weak negative association was noted.

Conclusions:

• Mitochondrial hearing loss exhibits significant phenotypic variability.
• The m.3243A>G mutation is linked to progressive hearing loss, while m.1555A>G is associated with stable hearing loss.
• Further longitudinal studies are needed to understand the natural progression and explore therapeutic interventions for mitochondrial hearing loss.